NEW YORK, Dec. 01, 2022 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company… Continue Reading
Articles
Blue Earth Diagnostics Announces Efficacy and Safety Results from Phase 3 LIGHTHOUSE Trial of Investigational PET Imaging Agent 18F-rhPSMA-7.3 in Newly Diagnosed Prostate Cancer
MONROE TOWNSHIP, N.J. & OXFORD, England–(BUSINESS WIRE)– Blue Earth Diagnostics a Bracco company and recognized leader in the development and commercialization of… Continue Reading
LIVTENCITY (maribavir) Receives Positive CADTH Recommendation for Adults with Post-Transplant Cytomegalovirus (CMV) Infection
The conditions for the positive recommendation is supported by the findings of the Phase 3 SOLSTICE Study.1,2 TORONTO, Dec. 1, 2022 /CNW/… Continue Reading
Otsuka and Sunovion Initiate Clinical Development of Ulotaront for the Adjunctive Treatment of Major Depressive Disorder
PRINCETON, N.J. & MARLBOROUGH, Mass.–(BUSINESS WIRE)– Otsuka Pharmaceutical Development & Commercialization, Inc. (Otsuka) and Sunovion Pharmaceuticals Inc. (Sunovion) today announced that… Continue Reading
Otsuka Pharmaceutical & Lundbeck Present Positive Data From Multiple Phase 3 Studies Showing Brexpiprazole Significantly Improved Symptoms of Agitation in Patients With Alzheimer’s Dementia
Researchers highlight efficacy and safety data across three Phase 3 studies of brexpiprazole for agitation in Alzheimer’s dementia Agitation is… Continue Reading
Lumen Raises $62M for Handheld Device to Measure Metabolic Health
What You Should Know: Lumen, the metabolic health company behind the first handheld device to measure your metabolism through the… Continue Reading
UCLA Spinout PictorLabs Launches with $18.8M to Revolutionize Histopathology
What You Should Know: PictorLabs launches with more than $18M in financing to advance an AI-powered virtual staining platform to revolutionize histopathology, an… Continue Reading
TrialSpark announces acquisition of a clinical-stage immunodermatology portfolio and formation of Libertas Bio
NEW YORK, Nov. 29, 2022 /PRNewswire/ — TrialSpark announced today the formation of Libertas Bio following the acquisition of a majority position… Continue Reading
AstraZeneca to Acquire Neogene Therapeutics, Accelerating Ambition in Oncology Cell Therapy
Acquisition provides access to next-generation T-cell receptor therapies with promising potential for targeting solid tumors SANTA MONICA, Calif. & AMSTERDAM–(BUSINESS… Continue Reading
Medeologix Acquires Three Silicon Valley Medical Device CDMO Companies and Establishes One-Stop Shop Mass Production Facilities in Taiwan
NEW TAIPEI CITY, Taiwan, Nov. 28, 2022 /PRNewswire/ — Medeologix, a Taiwan MedTech CDMO company announces its successful acquisition of three premier medical device manufacturing… Continue Reading